DiscoverMarket PathwaysPioneering the Use of Real-World Evidence in Medtech: A Discussion with J&J’s Paul Coplan
Pioneering the Use of Real-World Evidence in Medtech: A Discussion with J&J’s Paul Coplan

Pioneering the Use of Real-World Evidence in Medtech: A Discussion with J&J’s Paul Coplan

Update: 2024-08-01
Share

Description

The use of real-world evidence is increasing rapidly throughout the device industry. Here we talk with Paul Coplan, who is leading that effort at J&J, which received the first FDA-approved label extension using real-world evidence. Our conversation embraces the breadth of real-world evidence uses, including the recent FDA guidance, as well as global applications of real-world evidence, and its use in emerging areas like health equity and AI.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Pioneering the Use of Real-World Evidence in Medtech: A Discussion with J&J’s Paul Coplan

Pioneering the Use of Real-World Evidence in Medtech: A Discussion with J&J’s Paul Coplan

Market Pathways